| MeSH term | MeSH ID | Detail |
|---|---|---|
| Bacterial Infections | D001424 | 21 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Stomach Diseases | D013272 | 7 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Lung Neoplasms | D008175 | 171 associated lipids |
| Skin Neoplasms | D012878 | 12 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Leishmaniasis, Visceral | D007898 | 13 associated lipids |
| Diabetes Mellitus, Type 1 | D003922 | 56 associated lipids |
clarithromycin
clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.
Cross Reference
Introduction
To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with clarithromycin?
clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (63)
- J. Antimicrob. Chemother. (56)
- J. Clin. Microbiol. (39)
- Others (258)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with clarithromycin
PubChem Associated disorders and diseases
What pathways are associated with clarithromycin
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with clarithromycin?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Antimicrob. Chemother. (25)
- Antimicrob. Agents Chemother. (20)
- J. Clin. Microbiol. (9)
- Others (66)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with clarithromycin?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with clarithromycin?
Related references are published most in these journals:
- Antimicrob. Agents Chemother. (5)
- Drug Metab. Dispos. (1)
- FEMS Immunol. Med. Microbiol. (1)
- Others (5)
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with clarithromycin?
Related references are published most in these journals:
- J. Antimicrob. Chemother. (20)
- Antimicrob. Agents Chemother. (17)
- J. Clin. Microbiol. (13)
- Others (57)
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with clarithromycin?
Mouse Model
Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).
Knock-out
Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).
Experimental Pneumococcal Meningitis
Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).
Related references are published most in these journals:
| Model | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
NCBI Entrez Crosslinks
All references with clarithromycin
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Khurana R et al. | An update on anti-Helicobacter pylori treatment in children. | 2005 | Can. J. Gastroenterol. | pmid:16010308 |
| Chiba N et al. | Ranitidine bismuth citrate. | 2001 | Can. J. Gastroenterol. | pmid:11429668 |
| Chiba N and Marshall CP | Omeprazole once or twice daily with clarithromycin and metronidazole for Helicobacter pylori. | 2000 | Can. J. Gastroenterol. | pmid:10655024 |
| Hunt RH et al. | Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter Study Group. | 2000 | Can. J. Gastroenterol. | pmid:11111109 |
| Smaill F | Antibiotic susceptibility and resistance testing: an overview. | 2000 | Can. J. Gastroenterol. | pmid:11111110 |
| Fallone CA | Epidemiology of the antibiotic resistance of Helicobacter pylori in Canada. | 2000 | Can. J. Gastroenterol. | pmid:11111111 |
| Chiba N | Effects of in vitro antibiotic resistance on treatment: bismuth-containing regimens. | 2000 | Can. J. Gastroenterol. | pmid:11111112 |
| Yoh M et al. | Effect of subinhibitory concentrations of antimicrobial agents (quinolones and macrolide) on the production of verotoxin by enterohemorrhagic Escherichia coli O157:H7. | 1999 | Can. J. Microbiol. | pmid:10526400 |
| Altman E et al. | Lipopolysaccharide glycotyping of clarithromycin-resistant and clarithromycin-susceptible Canadian isolates of Helicobacter pylori. | 2014 | Can. J. Microbiol. | pmid:24392924 |
| Slany M et al. | Mycobacterium marinum infections in humans and tracing of its possible environmental sources. | 2012 | Can. J. Microbiol. | pmid:22182182 |
| Can F et al. | Diagnosis of Helicobacter pylori infection and determination of clarithromycin resistance by fluorescence in situ hybridization from formalin-fixed, paraffin-embedded gastric biopsy specimens. | 2005 | Can. J. Microbiol. | pmid:16175205 |
| Lee SB et al. | Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery. | 2005 | Can. J. Ophthalmol. | pmid:16391641 |
| Chan EY and Dell SD | Pediatric interstitial lung disease masquerading as difficult asthma: management dilemmas for rare lung disease in children. | 2005 | Can. Respir. J. | pmid:16247529 |
| Glezos JD et al. | Pneumonitis after inhalation of mercury vapours. | 2006 | Can. Respir. J. | pmid:16642230 |
| Sandrini A et al. | Diffuse panbronchiolitis in a Caucasian man in Canada. | 2003 Nov-Dec | Can. Respir. J. | pmid:14679410 |
| Weiss K et al. | Clinical characteristics at initial presentation and impact of dual therapy on the outcome of bacteremic Streptococcus pneumoniae pneumonia in adults. | 2004 Nov-Dec | Can. Respir. J. | pmid:15611810 |
| Marrie TJ et al. | Symptom resolution in patients with Mycoplasma pneumoniae pneumonia. | 2004 Nov-Dec | Can. Respir. J. | pmid:15611807 |
| Torresin A et al. | Vinca alkaloids and macrolides in human immunodeficiency virus-related malignancies: a safe association. | 1996 | Cancer Chemother. Pharmacol. | pmid:8995518 |
| Grosso F et al. | A comprehensive safety analysis confirms rhabdomyolysis as an uncommon adverse reaction in patients treated with trabectedin. | 2012 | Cancer Chemother. Pharmacol. | pmid:22484722 |
| Makihara K et al. | Clarithromycin co-administration does not increase irinotecan (CPT-11) toxicity in colorectal cancer patients. | 2017 | Cancer Chemother. Pharmacol. | pmid:28711984 |
| Chen Y et al. | In vitro assessment of cytochrome P450 inhibition and induction potential of azacitidine. | 2010 | Cancer Chemother. Pharmacol. | pmid:20119716 |
| Kane CL et al. | Disseminated cutaneous Mycobacterium chelonae infection. | 2000 Mar-Apr | Cancer Control | pmid:10783823 |
| Sarihan S et al. | Evaluation of infections in non-small cell lung cancer patients treated with radiotherapy. | 2005 | Cancer Detect. Prev. | pmid:15829379 |
| Uemura N et al. | Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. | 1997 | Cancer Epidemiol. Biomarkers Prev. | pmid:9264278 |
| Noonan KA et al. | Targeting immune suppression with PDE5 inhibition in end-stage multiple myeloma. | 2014 | Cancer Immunol Res | pmid:24878583 |
| Yatsunami J et al. | Roxithromycin and clarithromycin, 14-membered ring macrolides, potentiate the antitumor activity of cytotoxic agents against mouse B16 melanoma cells. | 1999 | Cancer Lett. | pmid:10660084 |
| Zhang S et al. | Early or late antibiotic intervention prevents Helicobacter pylori-induced gastric cancer in a mouse model. | 2015 | Cancer Lett. | pmid:25853150 |
| Oakman C et al. | Role of lapatinib in the first-line treatment of patients with metastatic breast cancer. | 2010 | Cancer Manag Res | pmid:21188093 |
| Lee CW et al. | Helicobacter pylori eradication prevents progression of gastric cancer in hypergastrinemic INS-GAS mice. | 2008 | Cancer Res. | pmid:18441088 |
| Cao X et al. | Eradication of Helicobacter pylori induces apoptosis and inhibits proliferation of heterotopic proliferative glands in infected Mongolian gerbils. | 2004 | Cancer Sci. | pmid:15546504 |
| Pan-In P et al. | Ethyl cellulose nanoparticles: clarithomycin encapsulation and eradication of H. pylori. | 2014 | Carbohydr Polym | pmid:24815396 |
| Zhang Y et al. | Helicobacter pylori, cyclooxygenase-2 and evolution of gastric lesions: results from an intervention trial in China. | 2015 | Carcinogenesis | pmid:26449252 |
| Thun MJ et al. | The global burden of cancer: priorities for prevention. | 2010 | Carcinogenesis | pmid:19934210 |
| Dingemanse C et al. | Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice. | 2015 | Carcinogenesis | pmid:26320104 |
| Escalante CP and Zalpour A | Vascular endothelial growth factor inhibitor-induced hypertension: basics for primary care providers. | 2011 | Cardiol Res Pract | pmid:21629798 |
| Winkel P et al. | Excess sudden cardiac deaths after short-term clarithromycin administration in the CLARICOR trial: why is this so, and why are statins protective? | 2011 | Cardiology | pmid:21447948 |
| Gluud C et al. | Clarithromycin for 2 weeks for stable coronary heart disease: 6-year follow-up of the CLARICOR randomized trial and updated meta-analysis of antibiotics for coronary heart disease. | 2008 | Cardiology | pmid:18451646 |
| Paz A and Potasman I | Mycoplasma-associated carditis. Case reports and review. | 2002 | Cardiology | pmid:11978954 |
| Andersen SS et al. | Clarithromycin use and risk of death in patients with ischemic heart disease. | 2010 | Cardiology | pmid:20523043 |
| Page RL et al. | An alternative salvage regimen for Helicobacter pylori-resistant patients with heart failure. | 2008 | Cardiology | pmid:17971660 |
| Wang YH et al. | Effects of multiple doses of clarithromycin on the pharmacokinetics of laropiprant in healthy subjects. | 2011 | Cardiovasc Ther | pmid:20337634 |
| Suzuki M et al. | A case of yellow nail syndrome with dramatically improved nail discoloration by oral clarithromycin. | 2011 | Case Rep Dermatol | pmid:22220146 |
| Salik D and Del Marmol V | Refractory Hand Ulceration: A Case of Chronic Ulceration and Sporotrichoid Spread in a Fish Tank Hobbyist following Mycobacterium marinum Infection. | 2011 | Case Rep Dermatol | pmid:21792350 |
| Wongkitisophon P et al. | Cutaneous Mycobacterium abscessus Infection Associated with Mesotherapy Injection. | 2011 | Case Rep Dermatol | pmid:21487459 |
| Kamijo F et al. | A Case of Mycobacterial Skin Disease Caused by Mycobacterium peregrinum, and a Review of Cutaneous Infection. | 2012 | Case Rep Dermatol | pmid:22548041 |
| Pasha SF et al. | Hemosuccus Pancreaticus in the Era of Capsule Endoscopy and Double Balloon Enteroscopy Complicated by Multifocal Mycobacterium chelonae/abscessus Infection. | 2007 | Case Rep Gastroenterol | pmid:21487470 |
| Abe Y et al. | Esophageal Adenocarcinoma Developing after Eradication of Helicobacter pylori. | 2011 | Case Rep Gastroenterol | pmid:21769287 |
| Asano N et al. | Signet Ring Cell Gastric Cancer Occurring after Radiation Therapy for Helicobacter pylori-Uninfected Mucosa-Associated Lymphoid Tissue Lymphoma. | 2011 | Case Rep Gastroenterol | pmid:21712948 |
| Shah M et al. | Transient Psychotic Episode Induced by Helicobacter pylori Triple Therapy Treatment. | 2012 | Case Rep Gastroenterol | pmid:22855656 |
| Hasosah M et al. | Mucosa-associated lymphoid tissue lymphoma of the lacrimal gland: sustained remission after eradication of helicobacter pylori infection. | 2011 | Case Rep Gastrointest Med | pmid:22606434 |
| Shimabukuro-Vornhagen A et al. | Acquired Long QT Syndrome and Torsade de Pointes Associated with HIV Infection. | 2010 | Case Rep Med | pmid:20827440 |
| Namendys-Silva SA et al. | Acute respiratory distress syndrome caused by influenza B virus infection in a patient with diffuse large B-cell lymphoma. | 2011 | Case Rep Med | pmid:22110513 |
| Bamias G et al. | Atypical mycobacterial infection presenting as persistent skin lesion in a patient with ulcerative colitis. | 2011 | Case Rep Med | pmid:22007233 |
| Folaranmi SE et al. | Suspected intestinal tuberculosis might be Crohn's disease. | 2010 | Case Rep Med | pmid:20490287 |
| Kurugol Z et al. | Severe Hemolytic Anemia Associated with Mild Pneumonia Caused by Mycoplasma pneumonia. | 2012 | Case Rep Med | pmid:23049568 |
| Cetin M et al. | Clarithromycin-Induced Long QT Syndrome: A Case Report. | 2012 | Case Rep Med | pmid:22489247 |
| Eruz ED et al. | A case of brucellosis presenting with multiple hypodense splenic lesions and bilateral pleural effusions. | 2011 | Case Rep Med | pmid:21687542 |
| Zenone T | Systemic Bartonella henselae Infection in Immunocompetent Adult Presenting as Fever of Unknown Origin. | 2011 | Case Rep Med | pmid:21629850 |
| Papacharalampous GX et al. | Bilateral Peritonsillar Abscesses: A Case Presentation and Review of the Current Literature with regard to the Controversies in Diagnosis and Treatment. | 2011 | Case Rep Med | pmid:21629820 |
| Ablanedo-Terrazas Y et al. | Palatal Actinomycosis and Kaposi Sarcoma in an HIV-Infected Subject with Disseminated Mycobacterium avium-intracellulare Infection. | 2012 | Case Rep Med | pmid:22481952 |
| Samet JD et al. | Cronkhite-Canada Syndrome: Gastric Involvement Diagnosed by MDCT. | 2009 | Case Rep Med | pmid:19721708 |
| Melo N et al. | Bordetella pertussis, an agent not to forget: a case report. | 2009 | Cases J | pmid:19200362 |
| Navaravong L et al. | Cigarettes-induced acute eosinophilic pneumonia: a case report. | 2008 | Cases J | pmid:19102783 |
| Del Castillo Y et al. | Interstitial lung disease associated to erlotinib treatment: a case report. | 2010 | Cases J | pmid:20509858 |
| Riordan AI et al. | Successful treatment with azithromycin and rifampicin of penicillin and cephalosporin insensitive pneumococcal osteomyelitis in a child with HIV infection: a case report. | 2008 | Cases J | pmid:18959805 |
| Christianakis E et al. | Pelvic plastron secondary to acute appendicitis in a child presented as appendiceal intussusception. A case report. | 2008 | Cases J | pmid:18761733 |
| Adejumo A et al. | Fatal dual infection with Salmonella and Mycobacterium avium complex infection in a patient with advanced acquired immunodeficiency syndrome: a case report. | 2009 | Cases J | pmid:20181177 |
| Ersoz F et al. | MALT lymphoma of the rectum, presenting with rectal prolapsus: a case report. | 2010 | Cases J | pmid:20180989 |
| Popalzai MJ et al. | Chronic fungal sinusitis leading to disastrous cerebral aspergillosis: a case report. | 2009 | Cases J | pmid:20069073 |
| Kassha K et al. | Severe Legionnaires disease complicated by multi-organ dysfunction in a previously healthy patient: a case report. | 2009 | Cases J | pmid:20062668 |
| Wiedmann M et al. | Sudden elevation of liver enzymes in a 64-year-old patient: a case report. | 2009 | Cases J | pmid:19946449 |
| Shaikh S et al. | Incomplete, atypical kawasaki disease or evolving systemic juvenile idiopathic arthritis: a case report. | 2009 | Cases J | pmid:19918500 |
| Frye SA and Decou JM | Pediatric bronchogenic cyst complicated by atypical mycobacterium infection: a case report. | 2009 | Cases J | pmid:19918449 |
| Abbott GW et al. | MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia. | 1999 | Cell | pmid:10219239 |
| Suzuki M et al. | Diversity of Cl(-) channels. | 2006 | Cell. Mol. Life Sci. | pmid:16314923 |
| Jakubů V et al. | Trends in the Minimum Inhibitory Concentrations of Erythromycin, Clarithromycin, Azithromycin, Ciprofloxacin, and Trimethoprim/Sulfamethoxazole for Strains of Bordetella pertussis isolated in the Czech Republic in 1967-2015. | 2017 | Cent. Eur. J. Public Health | pmid:29346850 |
| de Silva HA et al. | Comparison of one week and two weeks of triple therapy for the eradication of Helicobacter pylori in a Sri Lankan population: a randomised, controlled study. | 2004 | Ceylon Med J | pmid:15693450 |
| Lin TY et al. | An open-label, randomized comparison of levofloxacin and amoxicillin/clavulanate plus clarithromycin for the treatment of hospitalized patients with community-acquired pneumonia. | Chang Gung Med J | pmid:17939262 | |
| El-Enany NM et al. | Spectrofluorimetric determination of sertraline in dosage forms and human plasma through derivatization with 9-fluorenylmethyl chloroformate. | 2011 | Chem Cent J | pmid:21978386 |
| Sadeghi-Khomami A et al. | Glycosidase inhibition by macrolide antibiotics elucidated by STD-NMR spectroscopy. | 2008 | Chem. Biol. | pmid:18635010 |
| Nishimoto A et al. | Studies on macrolide antibiotics I. Synthesis and antibacterial activity of erythromycin A 9-O-substituted oxime ether derivatives against Mycobacterium avium complex. | 2001 | Chem. Pharm. Bull. | pmid:11558597 |
| Ishizaka T et al. | Bitterness evaluation of medicines for pediatric use by a taste sensor. | 2004 | Chem. Pharm. Bull. | pmid:15304986 |
| Rajinikanth PS et al. | Formulation and evaluation of clarithromycin microspheres for eradication of Helicobacter pylori. | 2008 | Chem. Pharm. Bull. | pmid:19043235 |
| Tanigake A et al. | The bitterness intensity of clarithromycin evaluated by a taste sensor. | 2003 | Chem. Pharm. Bull. | pmid:14600366 |
| Zhang X et al. | Effect of pore former on the properties of casted film prepared from blends of Eudragit NE 30 D and Eudragit L 30 D-55. | 2007 | Chem. Pharm. Bull. | pmid:17666856 |
| Fujiki S et al. | Stabilization mechanism of clarithromycin tablets under gastric pH conditions. | 2011 | Chem. Pharm. Bull. | pmid:21532191 |
| Yajima T et al. | Method of evaluation of the bitterness of clarithromycin dry syrup. | 2002 | Chem. Pharm. Bull. | pmid:11848199 |
| Tozuka Y et al. | Characterization and quantitation of clarithromycin polymorphs by powder X-ray diffractometry and solid-state NMR spectroscopy. | 2002 | Chem. Pharm. Bull. | pmid:12192153 |
| Tsuji E et al. | Evaluation of bitterness suppression of macrolide dry syrups by jellies. | 2006 | Chem. Pharm. Bull. | pmid:16508183 |
| Rajinikanth PS and Mishra B | Stomach-site specific drug delivery system of clarithromycin for eradication of Helicobacter pylori. | 2009 | Chem. Pharm. Bull. | pmid:19801860 |
| Ishii K et al. | In vitro dissolution tests corresponding to the in vivo dissolution of clarithromycin tablets in the stomach and intestine. | 1995 | Chem. Pharm. Bull. | pmid:8575034 |
| Yajima T et al. | Optimum heat treatment conditions for masking the bitterness of the clarithromycin wax matrix. | 2003 | Chem. Pharm. Bull. | pmid:14600362 |
| Ishizaka T et al. | The suppression of enhanced bitterness intensity of macrolide dry syrup mixed with an acidic powder. | 2007 | Chem. Pharm. Bull. | pmid:17917288 |
| Ishizaka T et al. | Quality of twelve clarithromycin dry syrup formulations-bitterness, grittiness and uniformity of drug loading. | 2008 | Chem. Pharm. Bull. | pmid:18827376 |
| Gattani SG et al. | Floating-mucoadhesive beads of clarithromycin for the treatment of Helicobacter pylori infection. | 2010 | Chem. Pharm. Bull. | pmid:20522987 |
| Koide T et al. | Analysis of Distribution of Ingredients in Commercially Available Clarithromycin Tablets Using Near-Infrared Chemical Imaging with Principal Component Analysis and Partial Least Squares. | 2015 | Chem. Pharm. Bull. | pmid:26329859 |
| Yajima T et al. | Optimum spray congealing conditions for masking the bitter taste of clarithromycin in wax matrix. | 1999 | Chem. Pharm. Bull. | pmid:10071855 |
| Li H et al. | Prediction of genotoxicity of chemical compounds by statistical learning methods. | 2005 | Chem. Res. Toxicol. | pmid:15962942 |
| Hur J et al. | Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis. | 2015 | Chem. Res. Toxicol. | pmid:25811541 |
| Loganathan B et al. | Contamination profiles and mass loadings of macrolide antibiotics and illicit drugs from a small urban wastewater treatment plant. | 2009 | Chemosphere | pmid:19121838 |